Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of <scp>MIPSS70</scp>+ v2.0 over <scp>MYSEC‐PM</scp>

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27226

Keywords:

Abstract:

Source: